Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Large-scale neuronal network dysfunction in multiple sclerosis?: Evidence from resting-state fMRI.
Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis.
A cluster randomised controlled trial on the efficacy of client-centred occupational therapy in multiple sclerosis: good process, poor outcome.
Riluzole attenuates excitatory amino acid transporter type 3 activity in Xenopus oocytes via protein kinase C inhibition.
Post-Partum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother.
PLA2G6 mutations and other rare causes of Neurodegeneration with Brain Iron Accumulation.
Neuromyelitis optica in a patient with pemphigus foliaceus.
Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies.
Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica.
A rare case of mixed connective tissue disease complicated with neuromyelitis optica.
[Neuromyelitis optica in the elderly: An unusual demyelinating disease.]
Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies.
Cerebellar-parietal dysfunctions in multiple sclerosis patients with cerebellar signs.
Quetiapine, an Atypical Antipsychotic, Is Protective against Autoimmune-Mediated Demyelination by Inhibiting Effector T Cell Proliferation.
Relapsing-remitting multiple sclerosis and chronic idiopathic neutropenia: a challenging combination.
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions.
Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension.
Role of the innate and adaptive immune responses in the course of multiple sclerosis.
Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation.
Association of a deficit of arousal with fatigue in multiple sclerosis: Effect of modafinil.
Dalfampridine improves walking speed, walking endurance, and community participation in veterans with multiple sclerosis: a longitudinal cohort study.
Evaluation of the effectiveness of home based or hospital based calisthenic exercises in patients with multiple sclerosis.
NMO spectrum presenting as partial myelitis.
Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
A population based cohort study to assess the safety of pandemic influenza vaccine Focetria(®) in Emilia-Romagna region, Italy-Part Two.
Pages
« first
‹ previous
…
212
213
214
215
216
217
218
219
220
…
next ›
last »